Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hernandez-Ruiz, L
Right arrow Articles by Ruiz, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernandez-Ruiz, L
Right arrow Articles by Ruiz, F.
Haematologica, Vol 91, Issue 9, 1180-1186
Copyright © 2006 by Ferrata Storti Foundation


Journal Article

Inorganic polyphosphate and specific induction of apoptosis in human plasma cells

L Hernandez-Ruiz, I Gonzalez-Garcia, C Castro, JA Brieva, and FA Ruiz

Unidad de Investigacion, Hospital Universitario Puerta del Mar, Cadiz, Spain.

BACKGROUND AND OBJECTIVES: Inorganic polyphosphate (polyP), a ubiquitous phosphate polymer with ATP-like bonds, has recently been related to a variety of functions including blood coagulation and cell proliferation. We investigated the effects of polyP in the biology of human plasma cells (PC), responsible for the production and maintenance of antibodies in response to antigens. DESIGN AND METHODS: The U266 myeloma cell line was used to study whether polyP affects immunoglobulin (Ig) secretion and survival. Different human cell lines were used to test the specificity of polyP on viability. We analyzed Ig secretion of PC from bone marrow and peripheral blood after polyP addition. A conventional tetanus toxoid booster immunization was used to increase the proportion of PC in order to examine the ex vivo effects of polyP. We also tested the effects of polyP on primary myeloma cells. Ig secretion and apoptosis were determined by ELISA and FACS respectively. RESULTS: Addition of polyP to human PC produced an unexpected inhibition of Ig secretion and stimulation of apoptosis. PolyP generated apoptosis specifically in PC, myeloma (malignant PC) cell lines, primary myeloma cells, and B lymphoid cell lines. Normal B cells, T cells, total blood mononuclear cells, and non-lymphoid cell lines were not affected by polyP. In the U266 myeloma cell line, polyP induced externalization of phosphatidylserine, activation of caspase-3, and arrest of the cell cycle. The protective effects of interleukin-6 did not overcome the polyP-induced apoptosis Interpretation and CONCLUSIONS: Taken together, our results suggest for the first time the relevance of the use of polyP to the humoral immune response and open prospects for polyP as a novel therapy for myeloma.


This article has been cited by other articles:


Home page
BloodHome page
S. A. Smith and J. H. Morrissey
Polyphosphate enhances fibrin clot structure
Blood, October 1, 2008; 112(7): 2810 - 2816.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Holbein, F. M. Freimoser, T. P. Werner, A. Wengi, and B. Dichtl
Cordycepin-hypersensitive growth links elevated polyphosphate levels to inhibition of poly(A) polymerase in Saccharomyces cerevisiae
Nucleic Acids Res., February 2, 2008; 36(2): 353 - 363.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Fang, F. A. Ruiz, M. Docampo, S. Luo, J. C. F. Rodrigues, L. S. Motta, P. Rohloff, and R. Docampo
Overexpression of a Zn2+-sensitive Soluble Exopolyphosphatase from Trypanosoma cruzi Depletes Polyphosphate and Affects Osmoregulation
J. Biol. Chem., November 2, 2007; 282(44): 32501 - 32510.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
Y. Hacchou, T. Uematsu, O. Ueda, Y. Usui, S. Uematsu, M. Takahashi, T. Uchihashi, Y. Kawazoe, T. Shiba, S. Kurihara, et al.
Inorganic Polyphosphate: a Possible Stimulant of Bone Formation
J. Dent. Res., September 1, 2007; 86(9): 893 - 897.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2006 by the Ferrata Storti Foundation.